Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile (CoMMpass)

Share this content:
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile (CoMMpass)
 
Sponsors and Collaborators
Multiple Myeloma Research Foundation
Millennium Pharmaceuticals, Inc.
Onyx Therapeutics, Inc.
Translational Genomics Research Institute, Phoenix, Arizona.
Spectrum Health Hospitals
Van Andel Research Institute
Quintiles
 
Contact
Beverly Harrison
203 652 0213
Harrisonb@themmrf.org
 
Quintiles Contact Center
1-866-776-3783
 
Principal Investigators
Beverly Harrison, BS
Multiple Myeloma Research Foundation
ClinicalTrials.gov Identifier
NCT01454297

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs